{"id":"https://openalex.org/W2900674262","doi":"https://doi.org/10.1080/2162402x.2018.1546068","title":"Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy","display_name":"Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy","alternate_titles":[],"publication_year":2018,"publication_date":"2018-11-22","ids":{"openalex":"https://openalex.org/W2900674262","doi":"https://doi.org/10.1080/2162402x.2018.1546068","mag":"2900674262","pmid":"https://pubmed.ncbi.nlm.nih.gov/30713806","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6343771"},"language":"en","primary_location":{"id":"doi:10.1080/2162402x.2018.1546068","doi":"https://doi.org/10.1080/2162402x.2018.1546068","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2018.1546068","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1546068?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2900674262"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1546068?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jing Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jing Liu","raw_affiliation_strings":["Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015401068","display_name":"Elisa A. Rozeman","orcid":"https://orcid.org/0000-0002-7063-651X","observed_orcids":["https://orcid.org/0000-0002-7063-651X"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisa A. Rozeman","raw_affiliation_strings":["Division of Molecular Oncology & Immunology, Netherlands Cancer Institute \u2013 Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology & Immunology, Netherlands Cancer Institute \u2013 Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054386807","display_name":"Jake S. O\u2019Donnell","orcid":"https://orcid.org/0000-0003-2960-7992","observed_orcids":["https://orcid.org/0000-0003-2960-7992"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jake S. O\u2019Donnell","raw_affiliation_strings":["Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]},{"raw_affiliation_string":"Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]},{"raw_affiliation_string":"School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080907108","display_name":"Stacey M. Allen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stacey Allen","raw_affiliation_strings":["Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077065834","display_name":"Lorenzo F. Fanchi","orcid":"https://orcid.org/0000-0002-5763-6726","observed_orcids":["https://orcid.org/0000-0002-5763-6726"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lorenzo Fanchi","raw_affiliation_strings":["Division of Molecular Oncology & Immunology, Netherlands Cancer Institute \u2013 Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-5763-6726","affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology & Immunology, Netherlands Cancer Institute \u2013 Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061575707","display_name":"Mark John Smyth","orcid":"https://orcid.org/0000-0001-7098-7240","observed_orcids":["https://orcid.org/0000-0001-7098-7240"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark J. Smyth","raw_affiliation_strings":["Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]},{"raw_affiliation_string":"School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088390068","display_name":"Christian U. Blank","orcid":"https://orcid.org/0000-0002-7945-5846","observed_orcids":["https://orcid.org/0000-0002-7945-5846"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian U. Blank","raw_affiliation_strings":["Division of Molecular Oncology & Immunology, Netherlands Cancer Institute \u2013 Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Oncology & Immunology, Netherlands Cancer Institute \u2013 Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007330428","display_name":"Michele W.L. Teng","orcid":"https://orcid.org/0000-0003-1886-9145","observed_orcids":["https://orcid.org/0000-0003-1886-9145"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michele W.L. Teng","raw_affiliation_strings":["Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I217937681"]},{"raw_affiliation_string":"School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I165143802"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5007330428"],"corresponding_institution_ids":["https://openalex.org/I165143802","https://openalex.org/I217937681"],"apc_list":{"value":2375,"currency":"GBP","value_usd":2913},"apc_paid":{"value":2375,"currency":"GBP","value_usd":2913},"fwci":2.1052,"has_fulltext":true,"cited_by_count":74,"citation_normalized_percentile":{"value":0.86825403,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"8","issue":"2","first_page":"e1546068","last_page":"e1546068"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4966000020503998,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.9929999709129333},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.7509999871253967},{"id":"https://openalex.org/keywords/anti-cd137","display_name":"anti-CD137","score":0.9810000061988831},{"id":"https://openalex.org/keywords/tumor-specific-cd8-t-cells","display_name":"tumor-specific CD8+ T cells","score":0.890999972820282},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.621999979019165},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8119999766349792},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.828000009059906},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.4519999921321869},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7840173840522766},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7556475400924683},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.6059509515762329},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.5496248006820679},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5440245866775513},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5430533289909363},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5154719948768616},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4947666525840759},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4943246841430664},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.47947391867637634},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4532999098300934},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.4307379424571991},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39890462160110474},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3619849681854248},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2848370671272278},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.25046080350875854},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.16794836521148682},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1287750005722046},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1080/2162402x.2018.1546068","doi":"https://doi.org/10.1080/2162402x.2018.1546068","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2018.1546068","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1546068?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5826325","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6343771","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6343771","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6343771/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Text"},{"id":"pmid:30713806","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30713806","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:9cb1a065726841ffad39b3e29814631f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9cb1a065726841ffad39b3e29814631f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoImmunology, Vol 8, Iss 2 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/2162402x.2018.1546068","doi":"https://doi.org/10.1080/2162402x.2018.1546068","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2018.1546068","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1546068?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1127499044","display_name":"Optimal scheduling of cancer surgery and adjuvant therapy","funder_award_id":"1099546","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G232668008","display_name":"Immunotherapy in cancer and virus infection","funder_award_id":"1132519","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G8648538585","display_name":"Returning Applicant to SPRF","funder_award_id":"1078671","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2900674262.pdf","grobid_xml":"https://content.openalex.org/works/W2900674262.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1994993231","https://openalex.org/W2060070314","https://openalex.org/W2084289643","https://openalex.org/W2108449579","https://openalex.org/W2143523733","https://openalex.org/W2149118203","https://openalex.org/W2164462649","https://openalex.org/W2180091996","https://openalex.org/W2341604280","https://openalex.org/W2511769828","https://openalex.org/W2521503673","https://openalex.org/W2529373149","https://openalex.org/W2564433363","https://openalex.org/W2612805962","https://openalex.org/W2655262992","https://openalex.org/W2741376942","https://openalex.org/W2744546677","https://openalex.org/W2752227448","https://openalex.org/W2797309423","https://openalex.org/W2798160602","https://openalex.org/W2894584497","https://openalex.org/W2894796660"],"related_works":["https://openalex.org/W3205548574","https://openalex.org/W2180091996","https://openalex.org/W2749046791","https://openalex.org/W4313359565","https://openalex.org/W2902555145","https://openalex.org/W2521503673","https://openalex.org/W2499312005","https://openalex.org/W2914793142","https://openalex.org/W2920151666","https://openalex.org/W4391847336"],"abstract_inverted_index":{"New":[0],"clinical":[1],"trials":[2],"are":[3],"now":[4,160],"evaluating":[5],"the":[6,12,19,40,60,119,124,142,165],"efficacy":[7],"of":[8,14,24,42,49,62,73,85,149,167],"neoadjuvant":[9,33,76,100,139,177],"immunotherapy":[10,34,77,102],"in":[11,39,94,110,118,123,153],"context":[13],"primary":[15,120],"tumor":[16,121,155],"surgery.":[17],"Using":[18],"orthotopic":[20],"4T1.2":[21,95],"mouse":[22],"model":[23],"spontaneously":[25],"metastatic":[26],"mammary":[27],"cancer,":[28],"we":[29,81,127],"have":[30],"shown":[31],"that":[32,83],"and":[35,47,65,122],"surgery":[36,54],"was":[37],"superior":[38],"generation":[41],"tumor-specific":[43,111],"CD8+":[44,112],"T":[45,113],"cells":[46,114],"eradication":[48],"lethal":[50],"metastases":[51],"compared":[52],"to":[53,176],"followed":[55],"by":[56],"adjuvant":[57,137],"immunotherapy.":[58,178],"However,":[59],"importance":[61],"host":[63],"Batf3":[64],"type":[66,89],"I":[67,90],"interferon":[68],"(IFN)":[69],"for":[70,174],"long-term":[71,104],"survival":[72,105],"mice":[74,97],"following":[75],"is":[78],"unknown.":[79],"Here":[80],"demonstrated":[82],"loss":[84],"Batf3+":[86,150,170],"DCs":[87],"or":[88,138],"IFN":[91],"receptor":[92],"blockade":[93],"tumor-bearing":[96],"treated":[98],"with":[99,106],"anti-PD-1+anti-CD137":[101],"reduced":[103],"a":[107],"corresponding":[108],"reduction":[109],"producing":[115],"effector":[116],"cytokines":[117],"periphery.":[125],"Interestingly,":[126],"found":[128],"all":[129],"high-risk":[130],"stage":[131],"III":[132],"melanoma":[133],"patients":[134],"relapsing":[135],"after":[136],"ipilimumab+nivolumab":[140],"within":[141],"OpACIN":[143],"trial":[144],"(NCT02437279)":[145],"displayed":[146],"low":[147],"expression":[148],"DC-associated":[151],"genes":[152],"pre-treatment":[154],"biopsies.":[156],"Further":[157],"focus":[158],"should":[159],"be":[161],"placed":[162],"on":[163],"validating":[164],"requirement":[166],"an":[168],"intratumoral":[169],"DC":[171],"gene":[172],"signature":[173],"response":[175]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2900674262","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-11-29T00:00:00"}
